MedReleaf Corp (TSE:LEAF) insider Olam Ltd. Tikun sold 28,600 shares of the company’s stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of C$25.00, for a total transaction of C$715,000.00.
Olam Ltd. Tikun also recently made the following trade(s):
- On Monday, January 29th, Olam Ltd. Tikun sold 1,000,000 shares of MedReleaf stock. The shares were sold at an average price of C$22.02, for a total transaction of C$22,020,000.00.
- On Tuesday, January 23rd, Olam Ltd. Tikun sold 29,300 shares of MedReleaf stock. The shares were sold at an average price of C$25.00, for a total transaction of C$732,500.00.
MedReleaf Corp (TSE LEAF) opened at C$19.90 on Thursday. MedReleaf Corp has a fifty-two week low of C$6.81 and a fifty-two week high of C$31.25. The stock has a market cap of $1,890.00 and a PE ratio of 995.00.
Several equities analysts have recently issued reports on the stock. Canaccord Genuity set a C$15.00 price objective on shares of MedReleaf and gave the company a “speculative buy” rating in a report on Thursday, November 2nd. Eight Capital upped their price objective on shares of MedReleaf from C$13.00 to C$20.00 and gave the company a “buy” rating in a report on Wednesday, November 15th. Finally, Cowen upped their price objective on shares of MedReleaf from C$20.00 to C$36.00 in a report on Monday, January 8th.
MedReleaf Company Profile
Medreleaf to list five million more shares Jan. 31
2018-01-29 10:07 ET - Prospectus Approved
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Tikun Olam Ltd. is the first, largest and foremost supplier of medical Cannabis in Israel, and one of leading medical cannabis companies in the world.
Tikun Olam is the flag bearer and pioneer of the treatment of patients with medical cannabis in Israel. The company is privately held and has been operating under license from the Israel Ministry of Health since 2007.
With The most extensive patient treatment database in the world and clinical research, Tikun Olam provides safe and suitable treatment – from pediatric to geriatric patients. Tikun Olam breeds unique proprietary cannabis strains and develops standardized consistent products with accurate dosage.Tikun Olam is a vertically integrated company – from plant to patient, founder of the first in world professional cannabis Nursing Clinic.
Since 2014 Tikun Olam cooperates with Medreleaf of Canada, to treat Canadian patients. In 2016 Tikun Olam expanded its business to the US and established a subsidiary company Tikun Olam USA. In 2017 Tikun Olam announces cooperation with Medifarm of Australia, Queensland's first medicinal cannabis growing licence.
and the stock is trading at $18.95 A Loss of $7.55 per share!!!
| House Positions for C:LEAF from 20180201 to 20180201 |
| House | Bought | $Val | Ave | Sold | $Val | Ave | Net | $Net |
|---|---|---|---|---|---|---|---|---|
| 79 CIBC | 138,849 | 2,694,554 | 19.406 | 41,352 | 813,360 | 19.669 | 97,497 | -1,881,194 |
| 11 Macquarie | 6,300 | 124,258 | 19.723 | 0 | 6,300 | -124,258 | ||
| 7 TD Sec | 32,029 | 623,234 | 19.458 | 26,332 | 512,066 | 19.447 | 5,697 | -111,168 |
| 2 RBC | 30,703 | 601,149 | 19.579 | 25,412 | 492,492 | 19.38 | 5,291 | -108,657 |
| 101 SG Capital | 8,200 | 162,435 | 19.809 | 3,200 | 64,068 | 20.021 | 5,000 | -98,367 |
| 124 Questrade | 13,626 | 269,858 | 19.805 | 8,679 | 174,620 | 20.12 | 4,947 | -95,238 |
| 22 Fidelity | 3,100 | 60,216 | 19.425 | 50 | 964 | 19.28 | 3,050 | -59,252 |
| 33 Canaccord | 11,953 | 235,073 | 19.666 | 9,100 | 178,118 | 19.573 | 2,853 | -56,955 |
| 99 Jitney | 8,000 | 155,533 | 19.442 | 5,700 | 111,263 | 19.52 | 2,300 | -44,270 |
| 58 Qtrade | 2,477 | 48,689 | 19.656 | 910 | 18,194 | 19.993 | 1,567 | -30,495 |
| 3 AltaCorp | 7,714 | 150,971 | 19.571 | 6,313 | 123,390 | 19.545 | 1,401 | -27,581 |
| 53 Morgan Stanley | 921 | 17,808 | 19.336 | 19 | 382 | 20.105 | 902 | -17,426 |
| 14 ITG | 700 | 13,721 | 19.601 | 0 | 700 | -13,721 | ||
| 57 Interactive | 875 | 16,893 | 19.306 | 305 | 6,065 | 19.885 | 570 | -10,828 |
| 25 Odlum | 500 | 9,500 | 19.00 | 0 | 500 | -9,500 | ||
| 83 Mackie | 500 | 9,630 | 19.26 | 0 | 500 | -9,630 | ||
| 9 BMO Nesbitt | 4,057 | 80,789 | 19.913 | 3,870 | 75,747 | 19.573 | 187 | -5,042 |
| 56 Edward Jones | 124 | 2,415 | 19.476 | 0 | 124 | -2,415 | ||
| 36 Latimer | 200 | 4,014 | 20.07 | 100 | 1,947 | 19.47 | 100 | -2,067 |
| 65 Goldman | 63 | 1,216 | 19.302 | 0 | 63 | -1,216 | ||
| 88 Credential | 45 | 900 | 20.00 | 0 | 45 | -900 | ||
| 85 Scotia | 20,811 | 404,159 | 19.42 | 21,053 | 412,968 | 19.616 | -242 | 8,809 |
| 143 Pershing | 390 | 7,544 | 19.344 | 702 | 13,671 | 19.474 | -312 | 6,127 |
| 28 BBS | 30 | 588 | 19.60 | 500 | 9,995 | 19.99 | -470 | 9,407 |
| 72 Credit Suisse | 26,718 | 519,109 | 19.429 | 28,010 | 542,816 | 19.379 | -1,292 | 23,707 |
| 74 GMP | 0 | 1,975 | 40,127 | 20.317 | -1,975 | 40,127 | ||
| 19 Desjardins | 510 | 10,200 | 20.00 | 3,781 | 74,727 | 19.764 | -3,271 | 64,527 |
| 89 Raymond James | 0 | 5,000 | 101,109 | 20.222 | -5,000 | 101,109 | ||
| 39 Merrill Lynch | 7,210 | 140,991 | 19.555 | 12,545 | 247,495 | 19.729 | -5,335 | 106,504 |
| 59 PI | 1,280 | 25,241 | 19.72 | 14,600 | 280,301 | 19.199 | -13,320 | 255,060 |
| 13 Instinet | 31,670 | 616,921 | 19.48 | 46,000 | 892,073 | 19.393 | -14,330 | 275,152 |
| 1 Anonymous | 108,690 | 2,132,946 | 19.624 | 139,553 | 2,730,757 | 19.568 | -30,863 | 597,811 |
| 80 National Bank | 15,753 | 315,172 | 20.007 | 78,937 | 1,537,012 | 19.471 | -63,184 | 1,221,840 |
| TOTAL | 483,998 | 9,455,727 | 19.537 | 483,998 | 9,455,727 | 19.537 | 0 | 0 |